2014 Canada Gairdner Recipients’ Lecture University of Toronto – Macleod Auditorium Thursday, October 30, 2014 – 9:00 am – 2:40 pm Thursday, October 30, 2014 9:00 am – 9:05 am Opening Session - Welcome Remarks 9:05 am – 9:10 am Introduction of speakers Dr. John Dirks President & Scientific Director, The Gairdner Foundation Chair – Dr. Alison Buchan, Vice Dean Research & International Relations, Faculty of Medicine, University of Toronto 2014 Canada Gairdner Recipients’ Lecture 9:10 am - 9:40am (30 mins) How shelterin solves the telomere end protection problem 9:40 am – 10:10 am (30 mins) VPF/VEGF: Vascular permeability & pathological angiogenesis in tumors, wounds & chronic inflammation 10:10 am -10:30 am (20 mins) 10:30 am -11:00 am (30 mins) Health Break The VEGF story: From basic discoveries to treating cancer & preventing blindness 11:00 am-11:30 am (30 mins) The impact of anti-TNF therapy on the treatment of rheumatoid arthritis and other chronic inflammatory diseases Lessons from antiTNF therapy 11:30 am – 12:00 pm (30 mins) 12:00 pm - 1:00 pm (Lunch by invitation only) Dr. Titia de Lange 2014 Canada Gairdner International Laureate, Rockefeller University, New York, NY, USA Dr. Harold Dvorak 2014 Canada Gairdner International Laureate, Beth Israel Deaconess Medical Center, Boston, MA, USA Dr. Napoleone Ferrara 2014 Canada Gairdner International Laureate, University of California, San Diego, La Jolla, CA, USA Dr. Ravinder Maini 2014 Canada Gairdner International Laureate, University of Oxford, Oxford, UK Sir. Marc Feldmann 2014 Canada Gairdner International Laureate, University of Oxford, Oxford, UK Lunch/Networking 2014 Canada Gairdner Recipients’ Lecture 1:00 pm – 1:05 pm (5 mins) Introduction of speakers 1:05 am -1:35 pm (30 mins) Targeting immune checkpoints in cancer therapy 1:35 pm - 2:05 pm (30 mins) A gift from the earth: The origins of Ivermectin 2:05 pm - 2:35 pm (30 mins) Why does cardiovascular disease vary between populations? 2:35 pm – 2:40 pm (5 mins) Closing Remarks Dr. Henry Friesen 1977 Canada Gairdner Laureate, 2001 Canada Gairdner Wightman Laureate, Distinguished Professor, University of Manitoba, Manitoba, Manitoba, CA Dr. James Allison 2014 Canada Gairdner International Laureate, University of Texas, Houston, USA Dr. Satoshi Omura 2014 Canada Gairdner Global Health Laureate, Kitasato University, Tokyo, Japan Dr. Salim Yusuf 2014 Canada Gairdner Wightman Laureate, McMaster University, Hamilton, ON, CA Dr. John Dirks President & Scientific Director, The Gairdner Foundation 2014 Gairdner Symposium New Advances in Biology and Treatment of Cancer University of Toronto – Macleod Auditorium Friday, October 31, 2014 – 8:45 a.m. – 4:00 p.m. Friday, October 31, 2014 8:45 am – 9:00am Opening Session - Welcome Remarks 9:00 am – 9:10 am Introduction of speakers Dr. Cal Stiller, 2010 Canada Gairdner Wightman Laureate Chair Dr. Tom Hudson President & Scientific Director, Ontario Institute of Cancer Research New Advances in Biology and Treatment of Cancer 9:10 am - 9:40am (30 mins) & 10 min. Q&A The breadth and value of cancer research 9:50 am – 10:20 am (30 mins) Stem cells in cancer: Do they matter? 10:20 am - 10:50 am (30 mins) Epigenetic therapy meets immunology 10:50 am -11:05 am (15 mins) 11:05 am -11:10 am (5 mins) Health Break Introduction of speakers 11:10 am-11:40 am (30 mins) What cancer is teaching us about cellular metabolism 11:40 am – 12:10 pm (30 mins) Oncolytic Viruses: Replicating Biological Machines for Cancer Therapy 12:10 pm - 1:00 pm Lunch/Networking (invitation only) Dr. Harold Varmus 1984 Gairdner Laureate, Director, National Cancer Institute, Bethesda, MD, USA Dr. John Dick Senior Scientist, Princess Margaret Cancer Centre; Professor, Department of Molecular Genetics, University of Toronto; Director, Cancer Stem Cell Program, OICR, Toronto Dr. Stephen Baylin Deputy Director, The Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA 10:40 am -10:55 am (15 mins) Linda Rabeneck, VP, Prevention & Cancer Control, Cancer Care Ontario, Toronto, CA Dr. Craig B. Thompson President, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Dr. John Bell, Senior Scientist, Cancer Therapeutics, Ottawa Hospital Research Institute New Advances in Biology and Treatment of Cancer 1:00 pm - 1:05 pm (5 mins) Introduction of speakers 1:05 am -1:35 pm (30 mins) Understanding and overcoming resistance to anticancer therapy with kinase Inhibitors: changing the landscape of practice with lessons from rare tumors Combination Approaches in Cancer Immunotherapy 1:35 pm – 2:05 pm (30 mins) 2:05 pm – 2:20 pm (15 mins) 2:20 pm – 2:25 pm (5 mins) Health Break Introduction of speakers 2:25 pm – 2:55 pm (30 mins) PD-1 Pathway blockade: mobilizing the immune system to treat cancer 2:55 pm -3:25 pm (30 Mins) CAR therapy and the promise of T cell engineering 3:25 pm – 4:00 pm Round Table Discussion 4:00 pm Closing Remarks Dr. Michael Julius, Vice President, Research, Sunnybrook Research Institute, Sunnybrook Health Sciences Center, Toronto, CA Dr. George Demetri Director, Ludwig Center at Harvard, Director, Center for Sarcoma & Bone Oncology, Harvard Medical School, Boston, MA, USA Dr. Jedd Wolchok Director, Center for Mechanism Based Therapy, Memorial Sloan-Kettering Cancer Center, NY, NY, USA Dr. Chris Paige, Vice President of Research, UHN, Toronto, CA Dr. Suzanne Topalian Director, Melanoma Program, Kimmel Cancer Center, Baltimore, MD, USA Dr. Michel Sadelain, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, USA All speakers plus Dr. James Allison and Dr. Napoleone Ferrara Dr. John Dirks, President & Scientific Director, The Gairdner Foundation
© Copyright 2024